Comparative Treatment Cost, Effectiveness and Safety of Dabigatran, Rivaroxaban and Warfarin in Atrial Fibrillation (AF) Patients: A Descriptive Study from Penang General Hospital (PGH)

W.L. Looi; S.K. Tan; H.Y. Yeo; A. Andin Selamat; A. Abdul Hanif; C. Priyadarshini

首页> 外文期刊>International Journal of Cardiology >Comparative Treatment Cost, Effectiveness and Safety of Dabigatran, Rivaroxaban and Warfarin in Atrial Fibrillation (AF) Patients: A Descriptive Study from Penang General Hospital (PGH)

【24h】

Comparative Treatment Cost, Effectiveness and Safety of Dabigatran, Rivaroxaban and Warfarin in Atrial Fibrillation (AF) Patients: A Descriptive Study from Penang General Hospital (PGH)

机译：达比税兰，罗西沙凡巴班和风耳其患者患者的达凡达兰和华法林的比较治疗成本，有效性和安全性：槟城综合医院（PGH）的描述性研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International Journal of Cardiology》 |2017年第2017期|共2页
作者
W.L. Looi; S.K. Tan; H.Y. Yeo; A. Andin Selamat; A. Abdul Hanif; C. Priyadarshini;
展开▼
作者单位

Pharmacy Department Penang General Hospital;

Pharmacy Department Penang General Hospital;

Clinical Research Centre Seberang Jaya Hospital;

Pharmacy Department Penang General Hospital;

Pharmacy Department Penang General Hospital;

Pharmacy Department Penang General Hospital;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Comparative Treatment Cost, Effectiveness and Safety of Dabigatran, Rivaroxaban and Warfarin in Atrial Fibrillation (AF) Patients: A Descriptive Study from Penang General Hospital (PGH) [J] . W.L. Looi, S.K. Tan, H.Y. Yeo, International Journal of Cardiology . 2017,第期

机译：达比税兰，罗西沙凡巴班和风耳其患者患者的达凡达兰和华法林的比较治疗成本，有效性和安全性：槟城综合医院（PGH）的描述性研究
2. Comparative effectiveness, safety, and costs of rivaroxaban and warfarin among morbidly obese patients with atrial fibrillation [J] . Peterson Eric D., Ashton Veronica, Chen Yen-Wen, The American heart journal . 2019,第期

机译：在心房颤动的病态肥胖患者中Rivaroxaban和Warfarin的比较有效性，安全性和成本
3. Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care [J] . Gorst-Rasmussen Anders, Lip Gregory Y. H., Larsen Torben Bjerregaard Pharmacoepidemiology and drug safety . 2016,第11期

机译：利伐沙班与华法林和达比加群在房颤中的作用：丹麦常规治疗中的相对有效性和安全性
4. Study on How Catheter Ablation Affects Atrial Structures in Patients with Paroxysmal Atrial Fibrillation: The Case of the Coronary Sinus [C] . Aikaterini Vraka, Vicente Bertomeu-González, Joaquín Osca, E-Health and Bioengineering Conference . 2020

机译：导管消融如何影响阵发性心房颤动患者心房结构的研究：冠状动脉窦的情况
5. Cost effectiveness of warfarin in anticoagulant clinic after introduction of dabigatran for stroke prevention in atrial fibrillation patients in the United States [D] . Alhazami, Mai S. 2015

机译：在美国引入达比加群后预防心房颤动患者中风后华法林在抗凝临床中的成本效益
6. Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation [O] . Faye L. Norby, Lindsay G.S. Bengtson, Pamela L. Lutsey, 2017

机译：利伐沙班与华法林或达比加群治疗非瓣膜性心房颤动的疗效比较
7. P3844Effectiveness, safety, and composite clinical outcomes of apixaban, dabigatran, rivaroxaban, relative to warfarin in non-valvular atrial fibrillation patients in the US Medicare population [O] . A Amin, A Keshishian, Q Zhang, 2018

机译：P3844紫杉醇，Dabigatran，Rivaroxaban的P3844效应，安全性和复合临床结果，相对于美国医疗保险人群的非瓣膜心房颤动患者的华法林

Comparative Treatment Cost, Effectiveness and Safety of Dabigatran, Rivaroxaban and Warfarin in Atrial Fibrillation (AF) Patients: A Descriptive Study from Penang General Hospital (PGH)

著录项

相似文献

相关主题

期刊订阅